Systemic immunoglobulin light chain amyloidosis is a disease characterized by the tissue accumulation of amyloid fibrillar aggregates, which leads to organ dysfunction. This Primer discusses the molecular mechanisms of this form of amyloidosis and highlights management strategies that have improved quality of life and survival.
- Giampaolo Merlini
- Angela Dispenzieri
- Morie A. Gertz
